UrologyNews.net

Urology Xagena

The androgen receptor inhibitor, Enzalutamide ( Xtandi ) is approved for the treatment of metastatic castration-resistant prostate cancer that has progressed on Docetaxel. A study has assessed the ac ...


Tadalafil ( Cialis ) is used to treat erectile dysfunction after prostate cancer treatment, but its role as a preventive agent is undefined. A study has assessed primarily whether Tadalafil preserv ...


Radical prostatectomy reduces mortality among men with localized prostate cancer; however, important questions regarding long-term benefit remain. Between 1989 and 1999, researchers have randomly a ...


Ipsen has announced positive results from its phase IIa clinical trial assessing Dysport in the treatment of neurogenic detrusor overactivity ( NDO ) in patients with urinary incontinence not adequate ...


Surgery is a craft profession requiring individuals with specific, well-documented innate aptitude for manipulative skills. Yet in most countries, the current selection process of surgical trainees do ...


The potential rehabilitative and protective effect of phosphodiesterase type 5 inhibitors ( PDE5-Is ) on penile function after nerve-sparing radical prostatectomy ( NSRP ) remains unclear. The prim ...


A second large, prospective study by researchers at Fred Hutchinson Cancer Research Center ( Seattle; United States ) has confirmed the link between high blood concentrations of Omega-3 fatty acids an ...


Data from the pivotal Phase III ALSYMPCA ( ALpharadin in SYMptomatic Prostate CAncer ) trial of its drug Radium 223 dichloride ( Radium 223 ) in castration-resistant prostate cancer patients with symp ...


A study, published in the Journal of Clinical Sleep Medicine, suggests that the bladder condition nocturia may worsen the already poor sleep of older adults with insomnia.The research has involved a g ...


Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer ...


Researchers has assessed effectiveness, safety, and tolerability of Paclitaxel or Fluorouracil when added to radiation plus Cisplatin followed by adjuvant chemotherapy in a programme of selected bladd ...


The FDA ( Food and Drug Administration ) has approved a product label addition for Cialis ( Tadalafil ) to include data from a 26-week study that showed Cialis 5 mg for once daily use started in combi ...


Replacing carbohydrates and animal fat with vegetable fat may be associated with a lower risk of death in men with nonmetastatic prostate cancer. Nearly 2.5 million men currently live with prostate ...


Avanafil ( Stendra, Spedra, Zepeeed ) is an oral phosphodiesterase type 5 inhibitor indicated for the treatment of erectile dysfunction. Avanafil is rapidly absorbed after oral administration, with ...


New research from the School of Medicine at The University of Texas Health Science Center San Antonio has indicated that eating a modest amount of walnuts can protect against prostate cancer. The s ...


In a study that included more than 10,000 men with nonmetastatic prostate cancer, use of androgen deprivation therapy ( ADT ) was associated with a significantly increased risk of acute kidney injury, ...


A new study from Harvard School of Public Health ( HSPH ) and Brigham and Women's Hospital researchers has found a strong association between the common sexually transmitted infection, Trichomonas vag ...


Two medications used to treat erectile dysfunction in men [ Tadalafil ( Cialis ) and Sildenafil ( Viagra ) ] do not appear to have visual side effects when taken daily for six months, despite concerns ...


Around 16% to 45% of adults have overactive bladder symptoms, urgency with frequency or urgency urinary incontinence, or both, termed overactive bladder syndrome. Anticholinergic drugs are common trea ...


An analysis has compared long-term urinary, bowel, and sexual function after radical prostatectomy or external-beam radiation therapy.The Prostate Cancer Outcomes Study ( PCOS ) enrolled 3533 men in w ...



2000-2014© XAGENA srl - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati